CRNX · NASDAQ · Biotechnology

Crinetics Pharmaceuticals (CRNX)

Develops oral GPCR medicines for endocrine diseases and endocrine-related tumors.

$84.95
0.00 (0.00%)
Delisted · Sep 2, 2026